Condition: Obesity · Weight Loss · Sponsor: University of Hohenheim
Obese individuals that undergo major intervention such as a low-calorie formula diet program or bariatric surgery with the result of substantial weight loss (\> 10%) are included and followed-up for at least 3 years. Weight changes and excess weight loss as well as measures of quality of life are monitored. In addition, biomaterials will be collected from these individuals every 6 months for measurement of parameters related to obesity-associated gastrointestinal (GI) impairments such as change in GI hormone levels, change in GI microbiota, or enhanced bacterial translocation. Moreover, micronutrient and metabolomics analysis will be performed. This project allows comparison of non-surgical and surgical intervention and enables to asses the anticipated relationship between obesity and the GI tract in humans in the future.
This description comes directly from the study's public registry record.
Antje Damms-Machado, Dipl. troph. · +49 711 451017707 · antje.machado@uni-hohenheim.de
Katrin Stingel, Dipl. troph. · +49 711 451017705 · k_stingel@uni-hohenheim.de
Always discuss trial participation with your own doctor first.
| University of Heidelberg | Heidelberg, Germany | Recruiting |
| University of Hohenheim | Stuttgart, Germany | Recruiting |
| University of Tübingen | Tübingen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01344525